acalabrutinib,ibrutinib
astrazeneca,abbvie,janssen
['acalabrutinib', 'leusm', 'cll']
ibrutinib improves time to next therapy vs acalabrutinib in real-world analysis of patients with cll #ash22 #leusm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.